Feed Top Reports Pricing

⌘K

00:15:08·21d

SECFiling

SEC Form EFFECT filed by Soligenix Inc.

SNGX· Soligenix Inc.

Health Care

Original source

Companies

SNGX
Soligenix Inc.
Health Care

Related

SEC21d
SEC Form EFFECT filed by Soligenix Inc.
SEC21d
SEC Form EFFECT filed by Soligenix Inc.
SEC21d
SEC Form EFFECT filed by Soligenix Inc.
PR21d
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
SEC23d
SEC Form POS AM filed by Soligenix Inc.
SEC23d
SEC Form POS AM filed by Soligenix Inc.
SEC23d
SEC Form POS AM filed by Soligenix Inc.
SEC23d
SEC Form POS AM filed by Soligenix Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022

SEC Form EFFECT filed by Soligenix Inc. | Quantisnow